335 related articles for article (PubMed ID: 23965432)
1. Immunotoxins: the role of the toxin.
Antignani A; Fitzgerald D
Toxins (Basel); 2013 Aug; 5(8):1486-502. PubMed ID: 23965432
[TBL] [Abstract][Full Text] [Related]
2. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
Mathew M; Verma RS
Cancer Sci; 2009 Aug; 100(8):1359-65. PubMed ID: 19459847
[TBL] [Abstract][Full Text] [Related]
3. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.
Kreitman RJ
BioDrugs; 2009; 23(1):1-13. PubMed ID: 19344187
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer Immunotoxins, Challenges, and Approaches.
Dashtiahangar M; Rahbarnia L; Farajnia S; Salmaninejad A; Shabgah AG; Ghasemali S
Curr Pharm Des; 2021; 27(7):932-941. PubMed ID: 33023437
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxins.
Press OW
Biotherapy; 1991; 3(1):65-76. PubMed ID: 2009215
[TBL] [Abstract][Full Text] [Related]
6. Patents on immunotoxins and chimeric toxins for the treatment of cancer.
Bachran C; Sutherland M; Bachran D; Fuchs H
Recent Pat Drug Deliv Formul; 2007; 1(2):105-15. PubMed ID: 19075878
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
Chiron MF
Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
[TBL] [Abstract][Full Text] [Related]
8. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
Brinkmann U
In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxins and cytokine toxin fusion proteins.
Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
Semin Immunol; 1990 Nov; 2(6):467-79. PubMed ID: 2104283
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
Potala S; Sahoo SK; Verma RS
Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
[TBL] [Abstract][Full Text] [Related]
11. Advances in anticancer immunotoxin therapy.
Alewine C; Hassan R; Pastan I
Oncologist; 2015 Feb; 20(2):176-85. PubMed ID: 25561510
[TBL] [Abstract][Full Text] [Related]
12. Toxin-labeled monoclonal antibodies.
Kreitman RJ
Curr Pharm Biotechnol; 2001 Dec; 2(4):313-25. PubMed ID: 11762413
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins: a clinical review of their use in the treatment of malignancies.
Hertler AA; Frankel AE
J Clin Oncol; 1989 Dec; 7(12):1932-42. PubMed ID: 2685183
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxin therapy of cancer.
Pastan I; Hassan R; Fitzgerald DJ; Kreitman RJ
Nat Rev Cancer; 2006 Jul; 6(7):559-65. PubMed ID: 16794638
[TBL] [Abstract][Full Text] [Related]
15. Bacterial Toxins for Cancer Therapy.
Zahaf NI; Schmidt G
Toxins (Basel); 2017 Jul; 9(8):. PubMed ID: 28788054
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxins and cytokine toxin fusion proteins.
Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
Ann N Y Acad Sci; 1991 Dec; 636():233-50. PubMed ID: 1793213
[TBL] [Abstract][Full Text] [Related]
17. Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes.
di Leandro L; Colasante M; Pitari G; Ippoliti R
Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133203
[TBL] [Abstract][Full Text] [Related]
18. Recombinant immunotoxins in targeted cancer cell therapy.
Reiter Y
Adv Cancer Res; 2001; 81():93-124. PubMed ID: 11430597
[TBL] [Abstract][Full Text] [Related]
19. Immunotoxins in cancer therapy: Review and update.
Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
[TBL] [Abstract][Full Text] [Related]
20. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
Lorberboum-Galski H
Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]